N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
Figures

N-terminal acetylation enhances synaptic vesicle (SV) clustering induced by α-synuclein (α-syn).
(a) α-syn is N-terminally acetylated in cells. Upper panel: Schematic representation of the delivery of 15N-labeled N-terminally unmodified α-syn (un-α-syn) into mammalian cells through electroporation. Lower panel: Comparisons of 2D 1H-15N HSQC spectra of N-acetylated α-syn (Ac-α-syn) (black) with in-buffer un-α-syn (blue) and in-cell un-α-syn (red). Distinct assignments for nuclear magnetic resonance (NMR) cross-peaks corresponding to amino acids in Ac-α-syn and un-α-syn are enclosed and labeled. (b) Scheme of experimental design for the functional study of Ac-α-syn on SV clustering. SVs isolated from mouse brains were added to Ac-α-syn (Upper) for measuring size distribution by dynamic light scattering (DLS) (middle panel), and the sample was further visualized by using negatively stained transmission electron microscopy (TEM) (lower panel). (c) The influences of N-acetylation of α-syn and (d) α-syn without the N-terminal thirty residues on SV clustering measured by DLS. The X-axis represents the number percent of the single SV and clustered SVs counted by DLS. Error bars are standard deviations from three biological replicates. **p-value <0.01; ***p-value <0.001; analysis by Student’s t-test. (e) Representative negatively stained TEM images of the single SV and clustered SVs in SV samples with no α-syn (gray) and Ac-α-syn (red), respectively. Figure 1—source data 1 (c&d): the DLS numerical data of SV&Ac-α-syn, SV&un-α-syn, SV&Δ30-α-Syn, and SV-only (three biological replicates of each sample).
-
Figure 1—source data 1
The DLS numerical data.
- https://cdn.elifesciences.org/articles/97228/elife-97228-fig1-data1-v1.xlsx

Lysophosphatidylcholine (LPC) mediates the enhancement of vesicle clustering by N-terminal acetylation of α-synuclein (α-syn).
(a) Scheme of single-vesicle clustering assay for the functional study of Ac-α-syn on vesicle clustering. Vesicles were prepared with different amounts of LPC, and were labeled with DiD or remained unlabeled, respectively. A saturated layer of unlabeled vesicles was immobilized on the imaging surface. Free DiD-vesicles were injected into the system with Ac-α-syn. Red laser illumination imaged the DiD-vesicles that clustered with unlabeled vesicles. The enhancement of LPC (b) and dioleoyl-phosphoserine (DOPS) (c) on single vesicle clustering count by Ac-α-syn and un-α-syn, respectively, was measured. Error bars are standard deviations from six random imaging locations in the same sample channel. *** indicates p-value <0.001, analysis by Student’s t-test.

N-terminal acetylation increases the α-synuclein (α-syn)–lysophosphatidylcholine (LPC) interaction.
Comparisons of residue-resolved nuclear magnetic resonance (NMR) signal intensity ratios (I/I0) of un-α-syn (upper) and Ac-α-syn (lower) during titration with LPC micelles (a), LPC-containing liposomes (DOPC:LPC = 4:1, mol:mol) (b), and dioleoyl-phosphoserine (DOPS) liposomes (c) at indicated protein/lipid molar ratios. Dashed lines highlight the residue positions 30 and 95. (d) SVs isolated from mouse brains were employed for NMR titration with 15N-Ac-α-syn, approximating the physiological ratio (α-syn:SV = 4000:300, mol:mol). Residue-resolved NMR signal intensity ratios (I/I0) of Ac-α-syn is titrated by synaptic vesicles (SVs) to that in solution. The molar ratios of SV to Ac-α-syn are indicated. LPC titration in the Ac-α-syn/LPC ratio of 1:10 (blue curve) is overlaid on the SV titration. (e) 2D 1H-15N HSQC spectra of NMR for un-α-syn with LPC micelles and Ac-α-syn with LPC micelles, LPC-containing liposomes, and mouse SVs. The NMR cross-peaks of the first 10 residues are highlighted and magnified, as depicted on the right side of each spectrum set (Note: the first and second residues of un-α-syn cannot be assigned). Figure 3—source data 1 (a–d): the NMR titration numerical data of α-syn&LPC, Ac-α-syn&LPC, Ac-α-syn&4PC/LPC, α-syn&DOPS, Ac-α-syn&DOPS, and Ac-α-syn&SV.
-
Figure 3—source data 1
The NMR titration numerical data.
- https://cdn.elifesciences.org/articles/97228/elife-97228-fig3-data1-v1.xlsx

Ac-α-syn binding on lysophosphatidylcholine (LPC) shows high intermolecular interactions.
(a) The cross-linking patterns of Ac-α-syn in the presence of LPC and dioleoyl-phosphoserine (DOPS) mapped by mass spectrometry (MS) at the protein/lipid molar ratio of 1:50. Lines present the inter-molecular cross-linked residues between two individual 15N-labeled and unlabeled Ac-α-syn. The grayscale of the lines corresponds to the frequency of the cross-linked pairs identified in three individual experiments. Source data are provided in Supplementary file 1a-f. (b) Ac-α-syn binds strongly to LPC through the N-terminal region (red arrow), and leaves more unbound NAC and C-terminal region for intermolecular interaction (green arrow). In contrast, N-terminal acetylation reduces α-syn’s binding to DOPS, and due to the negatively charged headgroup of PS, Ac-α-syn binding on DOPS extends to the NAC region, which limits intermolecular interactions. Supplementary file 1 (a-–c) Three biological replicates of identified cross-linked peptides between 15N-Ac-α-syn and 14N-Ac-α-syn in LPC; (d-e) Three biological replicates of identified cross-linked peptides between 15N-Ac-α-syn and 14N-Ac-α-syn in DOPS; Protein:lipid = 1:50, mol:mol.
Tables
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Escherichia coli) | BL21(DE3) | BioRad | 156–3003 | Electrocompetent cells |
Cell line (Homo-sapiens) | HEK-293T epithelial-like cells | ATCC | CRL-3216 | Cell line authentication services (STR profiling) are offered by ATCC, not detected mycoplasma contamination |
Transfected construct (human) | α-syn, Δ30 α-syn to pET22 vector | This paper; Zhao et al., 2024 | Constructs saved in C. Liu lab | |
Commercial assay or kit | Neon transfection system kit | Invitrogen | MPK5000 | |
Chemical compound, drug | 16:0 LPC, DOPC, DOPS, POPC, POPE, biotin-DPPE, cholesterol | Avanti Polar Lipids | 855675, 850375, 840035, 850457, 850757, 870277, 70000 | |
Chemical compound, drug | Disuccinimidyl suberate (DSS) | Thermo Scientific | 21658 | |
Chemical compound, drug | uranyl acetate | Sigma Aldrich | CDS021290 | |
Chemical compound, drug | DiD | Invitrogen | D307 | |
Software, algorithm | pLink | pLink | V1.9 | For XL-MS data |
Software, algorithm | SPARKY | SPARKY | V3.115 | For NMR data |
Software, algorithm | NMRpipe | NMRpipe | Build2018 | For NMR data |
Software, algorithm | smCamera | TJ Ha’s lab | For single vesicle data | |
Software, algorithm | Dynamics | Wyatt | V7.0 | For DLS data |
Other | C57BL6 mice | Lingchang Shanghai | 8 wk old, male |
Additional files
-
Supplementary file 1
Supplementary tables.
- https://cdn.elifesciences.org/articles/97228/elife-97228-supp1-v1.docx
-
MDAR checklist
- https://cdn.elifesciences.org/articles/97228/elife-97228-mdarchecklist1-v1.docx